You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 61 Issue 2

February 2006

Volume 61, Issue 2

Pages 121–242

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
      Medicines and the media (pages 121–122)

      J. K. Aronson

      Version of Record online: 19 JAN 2006 | DOI: 10.1111/j.1365-2125.2006.02580.x

  2. Review

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
      Drug safety and the media (pages 123–126)

      Patrick C. Waller, Stephen J. W. Evans and Keith Beard

      Version of Record online: 27 OCT 2005 | DOI: 10.1111/j.1365-2125.2005.02528.x

  3. Pharmacodynamics

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
      Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise (pages 127–137)

      Robinson Joannides, Nicholas Moore, Michaela Iacob, Patricia Compagnon, Guy Lerebours, Jean-François Menard and Christian Thuillez

      Version of Record online: 20 DEC 2005 | DOI: 10.1111/j.1365-2125.2005.02544.x

    2. You have free access to this content
      A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans (pages 138–147)

      Marie Magnusson, Ingar C. Bergstrand, Sven Björkman, Anders Heijl, Bodil Roth and Peter Höglund

      Version of Record online: 20 DEC 2005 | DOI: 10.1111/j.1365-2125.2005.02549.x

  4. Pharmacokinetics

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
      Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism (pages 148–154)

      David Burger, Ilse Van Der Heiden, Charles La Porte, Marchina Van Der Ende, Paul Groeneveld, Clemens Richter, Peter Koopmans, Frank Kroon, Herman Sprenger, Jan Lindemans, Paul Schenk and Ron Van Schaik

      Version of Record online: 11 NOV 2005 | DOI: 10.1111/j.1365-2125.2005.02536.x

    2. You have free access to this content
      Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding (pages 155–163)

      John Kim, K. Wayne Riggs, Shaila Misri, Nancy Kent, Tim F. Oberlander, Ruth E. Grunau, Colleen Fitzgerald and Dan W. Rurak

      Version of Record online: 28 NOV 2005 | DOI: 10.1111/j.1365-2125.2005.02538.x

    3. You have free access to this content
  5. Pharmacokinetics & pharmacodynamics

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
  6. Drug interactions

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
    2. You have free access to this content
      Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction (pages 200–210)

      Kwee Poo Yeo, Stephen L. Lowe, Ming Tung Lim, James R. Voelker, Jennifer L. Burkey and Stephen D. Wise

      Version of Record online: 22 DEC 2005 | DOI: 10.1111/j.1365-2125.2005.02540.x

  7. Therapeutics

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
      A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis (pages 211–217)

      Jose A. Simoes, Luis G. Bahamondes, Rodrigo P. S. Camargo, Valeria M. N. Alves, Lourens J. D. Zaneveld, Donald P. Waller, Jill Schwartz, Marianne M. Callahan and Christine K. Mauck

      Version of Record online: 1 DEC 2005 | DOI: 10.1111/j.1365-2125.2005.02550.x

  8. Pharmacoepidemiology

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
      Polypharmacy and falls in the middle age and elderly population (pages 218–223)

      G. Ziere, J. P. Dieleman, A. Hofman, H A. P. Pols, T. J. M. Van Der Cammen and B. H. CH. Stricker

      Version of Record online: 1 DEC 2005 | DOI: 10.1111/j.1365-2125.2005.02543.x

  9. Short reports

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
    2. You have free access to this content
      Warfarin use and the risk of motor vehicle crash in older drivers (pages 229–232)

      J. A. ‘Chris’ Delaney, Lucie Opatrny and Samy Suissa

      Version of Record online: 1 DEC 2005 | DOI: 10.1111/j.1365-2125.2005.02548.x

    3. You have free access to this content
  10. Letters to the editors

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Authors’ response : Adverse drug reactions to NSAIDs (pages 240–241)

      Thirza Titchen, Noel Cranswick and Sean Beggs

      Version of Record online: 11 NOV 2005 | DOI: 10.1111/j.1365-2125.2005.02535.x

  11. Book review

    1. Top of page
    2. Editors' view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics & pharmacodynamics
    7. Drug interactions
    8. Therapeutics
    9. Pharmacoepidemiology
    10. Short reports
    11. Letters to the editors
    12. Book review
    1. You have free access to this content
      Cannabinoids as Therapeutics (page 242)

      Ruth A. Ross

      Version of Record online: 7 NOV 2005 | DOI: 10.1111/j.1365-2125.2005.02537.x

SEARCH

SEARCH BY CITATION